Publications

Medicines Monitoring - New Medicines Added

This article is more than five years old. Some content may no longer be current.

Prescriber Update 33(3): 30
September 2012

Please send your reports for these potential safety issues* listed in the table below.

Medicine	Potential safety issue	Active monitoring period ends*
Sildenafil	Thromboembolism	30 September 2012
Cetirizine	Severe Mood Disorder	30 September 2012
SRIs	Thunderclap headache/RCVS	31 December 2012
Triptans	Thunderclap headache/RCVS	31 December 2012
Lithium	Diabetes mellitus	31 December 2012
Lansoprazole, Pantoprazole, Omeprazole	Hypocalcaemia	31 December 2012

is a Medsafe scheme designed to collect more information on potential safety signals for specific medicines.
Safety signals are identified from reports of adverse medicine reactions sent to the Centre for Adverse Reactions Monitoring (CARM). For further information see the Medsafe website.
The scheme does not replace routine adverse reaction reporting. Find out how to report at: https://nzphvc.otago.ac.nz/report/ or www.medsafe.govt.nz/safety/report-a-problem.asp

CARM logo

*The appearance of a possible safety issue in this scheme does not mean Medsafe and CARM have concluded that this medicine causes the reaction.